hemispherx biopharma inc (HEB:NYSE Amex)
Thomas K. Equels Esq.
Executive Vice Chairman, Chief Financial Officer, General Counsel, Secretary, Member of Executive Committee, Member of Disclosure Controls Committee and Member of Strategic Planning Committee, Hemispherx Biopharma, Inc.
|Age||Total Calculated Compensation||This person is connected to 6 board members in 1 different organizations across 1 different industries.|
See Board Relationships
As of Fiscal Year 2014
Mr. Thomas K. Equels, also known as Tom, Esq. serves as the President and Managing Director of Equels Law Firm. Mr. Equels has been the Chief Financial Officer of Hemispherx Biopharma, Inc. since December 4, 2013. He has been a General Counsel and Secretary of Hemispherx Biopharma, Inc. since January 1, 2010 and April 2009 respectively. He has been Litigation Counsel of Hemispherx Biopharma Inc., in a number of complex cases over ten years. He served as Managing Director ...
One Penn CenterPhone: 215-988-0080
Philadelphia, Pennsylvania 19103
Board Members Memberships*
Executive Vice Chairman, Chief Financial Officer, General Counsel, Secretary, Member of Executive Committee, Member of Disclosure Controls Committee and Member of Strategic Planning Committee
Florida State University
|Frank Mathias||Chief Executive Officer and Member of Executive Board|
|Brenton L. Saunders J.D.||Chief Executive Officer, President and Director|
|Robert L. Parkinson Jr.||Chairman, Chief Executive Officer and President|
Baxter International Inc.
|Pascal Soriot||Chief Executive Officer, Executive Director and Member of Disclosure Committee|
|Edward M. Kaye M.D., Ph.D.||Interim Chief Executive Officer, Chief Medical Officer and Senior Vice President|
Sarepta Therapeutics, Inc.
|$399.0K||Compensation as of Fiscal Year 2014.|